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Objectıve: To assess whether Glu298Asp polymorphism of the endothelial nitric
oxide sytnhase (eNOS) gene is associated with the occurrence of coronary no-reﬂow
phenomenon.
Background: Genetic variants of endothelial nitric oxide synthase (eNOS) could
inﬂuence individual susceptibility to coronary artery disease. Nitric oxide gene
polymorphisms can effect both production and functions of nitric oxide and therfore
may cause endothelial dysfunction. We hypothesized that Glu298Asp polymorphism
of the eNOS gene may be associated with coronary no-reﬂow devolopment in patients
with ST elevation myocardial infarction (STEMI) undergoing primary percutenous
intervention.
Materials: We included 121 patients with STEMI that underwent primary percute-
nous coronary intervention. Of 121 patients 57 patients had coronary no-reﬂow and 64
patients were without coronary no-reﬂow. Coronary noreﬂow was deﬁned as
Thrombolysis In Myocardial Infarction ﬂow grade 2 or less after intervention.
Genotype was determined by polymerase chain reaction.
Results: Patient and control groups were simillar in terms of sex, age, diabetes, body
mass index, hypertension and family history. Gensini and Syntax scores were lower in
control group (47.1324.8 vs 67.426.85 and 17.948.03 vs 25.4810.3 p¼0.001
p¼0.001 respectively).In admission serum creatinine and blood glucose levels were
lower in control group (0.840.17 vs 0.930.32 and 144.8774.78 vs 177.1694.42
p¼0.004, p¼0.0041 respectively). Initial and peak troponin levels were also lower in
control group (0.25 [0.04-2.82] vs 1.55 [0.15-8.87] and 3.15 [1.28-8.52] vs 10 [3.6-
25] p¼0.025, p¼0.0001 respectively). Neutrophil count and neutrophil to lymphocyte
ratio was higher in noreﬂow group (8754.763428.08 vs10325.183950.56 and 5
[2.28-6.82] vs 7 [4.14-9.81] p¼0.0025, p¼0.001 respectively). The genotype
frequencies of Glu298Asp polymorphism in control subjects were 59.38% for Glu/
Glu, 39.06% for Glu/Asp, and 1.56% for Asp/Asp. On the other hand, in no-reﬂow
patients, the genotype frequencies were 40.38% for Glu/Glu, 48.08% for Glu/Asp, and
11.54% for Asp/Asp. There was no statistically signiﬁcant difference in terms of Glu/
Glu and Glu/Asp polymorphisms between two groups. The proportion of Asp298
homozygotes was 11.54% in the no-reﬂow group and 1.56% in control group
(p¼0.032). In comparison with Glu/Glu genotype, the odds ratio (OR) for no-reﬂow
occurence associated with the Asp/Asp genotype was 10.86 (1.22-96.39)
Conclusıon: In our study we found a signiﬁcant association between Glu298Asp
polymorphism of the eNOS gene and coronary noreﬂow phenomenon. Nitric oxide is
one of the mediators that regulates endothelial functions and vascular tone. Poly-
morphisms at eNOS gene may adversely effect both production and function of nitric
oxide. Coronary no-reﬂow phenomenon has multipl mechansims. Endothelial
dysfunction and vasular spasm are also accused for no-reﬂow devolopment.
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Background and Aım: In severe aortic stenosis (AS), electrophysiological changes
are observed following mechanical stretch due to pressure overload. This electrical
instability observes as development of after depolarization and dispersion of repo-
larization. The aim of this study was evaluated the ventricular repolarization changes
following transcatheter valve implantation (TAVI).
Materıal-Methods: A prospective analysis of echocardiography and electrocardiog-
raphy was evaluated before TAVI, same day and 1 week later. Ventricular repolari-
zation was assessed with QT, QTc and in terms of dispersion across the myocardium;
QT, QTc dispersion (QTD, QTDc). Twelve lead electrocardiography (ECG) was
recorded for each subjects at a rate of 25 mm/s and 10 mm/V gain. The QT intervalsC238 JACC Vowere taken to be from the onset of the QRS to the end of the T wave. If U waves were
present, the QT interval was measured to the nadir of the curve between the T and U
waves. The measurements of the QT duration were performed manually by two of the
investigators. To improve accuracy, measurements were performed with calipers and
magnifying lens for deﬁning the ECG deﬂection.
Results: 70 consecutive patients (male/female:19/51, age: 77,6 years, AS max/mean
gradient: 85,2/52,8 mmHg, left ventricular ejection fraction:54,8%), diagnosed inop-
erable/high surgical risk severe aortic stenosis (logistic euroscore:%21,7, STS:7.7),
were included the study. Before TAVI, QT dispersion and QTc dispersion were
correlated with mean aortic valve area (p<0.001). There was statistically signiﬁcant
difference in QT dispersion and QTc dispersion (p<0.001). Patients’ QTD, QTDc
after TAVI (73.625.7, 74.829,4 respectively; QTD p: 0.044, QTDc p:0.030) and
1st week after TAVI (63.827.7, 66.130.6 respectively; QTD p<0.001, QTDc
p<0.001) was signiﬁcantly lower than before the TAVI (80.825.9, 83,326,4
respectively). Also statistically signiﬁcant difference of QTD, QTDc were observed
between after TAVI and 1st week after TAVI (QTD p:0.003, QTDc p:0.014).
Conclusıon: Sudden cardiac death (SCD) is major causes of death in patients with
severe aortic stenosis, and also ventricular tachycardia, ventricular ﬁbrillation are
major causes of SCD. Decrease mechanical stretch due to pressure overload after
TAVI, can also reduction across the myocardium of the dispersion of ventricular
repolarization and could be risk reduction in patients with signiﬁcant symptomatic
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